Drugs / retroviral SF71-gp91phox transduced CD34+ cells
retroviral SF71-gp91phox transduced CD34+ cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00927134 | Jun 2004 → Dec 2010 | chronic granulomatous disease | University of Zurich | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | retroviral SF71-gp91phox transduced CD34+ cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00927134 ↗ |
| Modality | Cell therapy | “autologous ex-vivo transduced (SF71-gp91phox)CD34+ cells” NCT00927134 ↗ |